On Aug. 30, 2021, AXIMﾮ Biotechnologies announced that the Companyﾒs manufacturing partner Empowered Diagnostics had filed an amended emergency use authorization with the Food and Drug Administration for ImmunoPassﾙ, the Companyﾒs rapid test that detects COVID-19 neutralizing antibodies at point-of-care locations.